Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study.
暂无分享,去创建一个
H. Stellbrink | C. Orkin | Kimberly Smith | H. Crauwels | W. Spreen | A. Cutrell | H. Katner | M. S. St. Clair | S. Ford | P. Patel | E. Birmingham | R. van Solingen-Ristea | K. Vandermeulen | D. Tan | Sandy Griffith | R. D'Amico | E. Belonosova | E. Bernal Morell | S. Thiagarajah | R. Demoor